BB Biotech AG

40
Sell
  • Market Cap: N/A
  • Industry: Finance
  • ISIN: CH0038389992
CHF
42.85
-14.45 (-25.22%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Operating Income
76.00
62.00
-17.00
-28.00
307.00
280.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
76.00
62.00
-17.00
-28.00
307.00
280.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
0.00
0.00
0.00
0.00
0.00
0.00
General and Administration Expenses
27.00
28.00
32.00
40.00
56.00
47.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
-8.00
0.00
0.00
0.00
0.00
-1.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
-510.00
-14.00
188.00
328.00
711.00
-412.00
Operating Profit (PBDIT) excl Other Income
586.00
76.00
-206.00
-357.00
-404.00
693.00
Other Income
-8.00
0.00
0.00
0.00
0.00
-1.00
Operating Profit (PBDIT)
578.00
76.00
-206.00
-357.00
-404.00
691.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Taxation & Exceptional Items
578.00
75.00
-206.00
-357.00
-404.00
691.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
578.00
75.00
-206.00
-357.00
-404.00
691.00
Provision for Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
578.00
75.00
-206.00
-357.00
-404.00
691.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
10.54
1.38
-3.77
-6.50
-7.31
12.48
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 23.63% vs 459.90% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 667.65% vs 137.09% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -9.96% vs 10.31% in Dec 2024

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2025 is 661.71% vs 136.74% in Dec 2024

Compare Profit and Loss Results of BB Biotech AG
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(CHF)
Change(%)
No of Months
12
12
Operating Income
76.00
112.00
-36.00
-32.14%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
76.00
112.00
-36.00
-32.14%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
0.00
20.00
-20.00
-100.00%
General and Administration Expenses
27.00
267.00
-240.00
-89.89%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
-8.00
0.00
-8.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
-510.00
455.00
-965.00
-212.09%
Operating Profit (PBDIT) excl Other Income
586.00
-343.00
929.00
270.85%
Other Income
-8.00
126.00
-134.00
-106.35%
Operating Profit (PBDIT)
578.00
-199.00
777.00
390.45%
Interest
0.00
20.00
-20.00
-100.00%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
0.00
17.00
-17.00
-100.00%
Profit Before Taxation & Exceptional Items
578.00
0.00
578.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
578.00
-263.00
841.00
319.77%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
578.00
-263.00
841.00
319.77%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
10.5412
-1.4457
11.99
829.14%
Profit And Loss - Net Sales
Net Sales 76.81 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 23.63% vs 459.90% in Dec 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 586.83 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 667.65% vs 137.09% in Dec 2024

Profit And Loss - Interest
Interest 0.44 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -9.96% vs 10.31% in Dec 2024

Profit And Loss - Profit After Tax
Profit After Tax 578.13 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 661.71% vs 136.74% in Dec 2024